1997
DOI: 10.1006/meth.1996.0389
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the Structure, Regulation, and Pathogenic Potential of Anti-dsDNA Antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
32
0

Year Published

1999
1999
2013
2013

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(33 citation statements)
references
References 0 publications
1
32
0
Order By: Relevance
“…It is therefore likely that a mutation in the mAb BDM2 may interfere with the recognition of dsDNA. Several different antigenic cross-reactivities have been identified for the anti-DNA Abs (29). These Abs share structural similarities with the Abs against bacterial polysaccharide, and some cross-react with the bacterial polysaccharide and protect mice against a lethal bacterial infection (30,31).…”
Section: Discussionmentioning
confidence: 99%
“…It is therefore likely that a mutation in the mAb BDM2 may interfere with the recognition of dsDNA. Several different antigenic cross-reactivities have been identified for the anti-DNA Abs (29). These Abs share structural similarities with the Abs against bacterial polysaccharide, and some cross-react with the bacterial polysaccharide and protect mice against a lethal bacterial infection (30,31).…”
Section: Discussionmentioning
confidence: 99%
“…3 Of interest, the anti-DNA mAb raised from the BALB/c mice immunized with the 4-hydroxy-2-nonenal-modified protein has been shown to crossreact with the ONE-modified protein (13). Several different antigenic cross-reactivities have been identified for the anti-DNA antibodies (27). These antibodies share structural similarities with antibodies against bacterial polysaccharide, and some cross-react with the bacterial polysaccharide and protect mice against a lethal bacterial infection (28,29).…”
Section: Discussionmentioning
confidence: 99%
“…4 In addition, we have examined the affinity of the anti-DNA mAbs D431 and D466 obtained from the 56R and CD40L double transgenic mice (33,34), a spontaneous murine model of SLE, with the ONE-modified protein and have found that, of the two anti-DNA mAbs, mAb D466 cross-reacted with the ONE-modified BSA. 4 Several different antigenic cross-reactivities have been identified for the anti-DNA antibodies (35). These antibodies share structural similarities with antibodies against bacterial polysaccharide, and some cross-react with the bacterial polysaccharide and protect mice against a lethal bacterial infection (36,37).…”
Section: Discussionmentioning
confidence: 99%